Filter News
Area of Research
- (-) Neutron Science (12)
- (-) Nuclear Science and Technology (10)
- Advanced Manufacturing (3)
- Biology and Environment (63)
- Building Technologies (1)
- Clean Energy (53)
- Climate and Environmental Systems (4)
- Computational Engineering (3)
- Computer Science (12)
- Fusion and Fission (15)
- Fusion Energy (8)
- Isotope Development and Production (1)
- Isotopes (17)
- Materials (28)
- Materials for Computing (4)
- Mathematics (1)
- National Security (22)
- Quantum information Science (4)
- Supercomputing (55)
News Type
News Topics
- (-) Computer Science (7)
- (-) Cybersecurity (1)
- (-) Environment (4)
- (-) Fusion (4)
- (-) Isotopes (3)
- (-) Space Exploration (6)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (7)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (5)
- Biology (4)
- Biomedical (8)
- Biotechnology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Composites (1)
- Coronavirus (5)
- Decarbonization (2)
- Energy Storage (4)
- Frontier (1)
- High-Performance Computing (1)
- Materials (9)
- Materials Science (17)
- Microscopy (2)
- Molten Salt (3)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (69)
- Nuclear Energy (21)
- Physics (9)
- Quantum Science (5)
- Security (1)
- Summit (4)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (4)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.